94 related articles for article (PubMed ID: 2861427)
1. Poor sulphoxidation in primary biliary cirrhosis.
Olomu A; Clements D; Waring R; Elias E
Lancet; 1985 Jun; 1(8444):1504. PubMed ID: 2861427
[No Abstract] [Full Text] [Related]
2. Sulphoxidation and sulphation capacity in patients with primary biliary cirrhosis.
Davies MH; Ngong JM; Pean A; Vickers CR; Waring RH; Elias E
J Hepatol; 1995 May; 22(5):551-60. PubMed ID: 7650336
[TBL] [Abstract][Full Text] [Related]
3. Impaired sulfoxidation in primary biliary cirrhosis.
Elias E; Waring R
Hepatology; 1989 Dec; 10(6):1027. PubMed ID: 2583682
[No Abstract] [Full Text] [Related]
4. High incidence of poor sulfoxidation in patients with primary biliary cirrhosis.
Olomu AB; Vickers CR; Waring RH; Clements D; Babbs C; Warnes TW; Elias E
N Engl J Med; 1988 Apr; 318(17):1089-92. PubMed ID: 3281015
[TBL] [Abstract][Full Text] [Related]
5. Cytosolic sulphoxidation of S-carboxymethyl-L-cysteine in mammals.
Waring RH; Mitchell SC; O'Gorman J; Fraser M
Biochem Pharmacol; 1986 Sep; 35(18):2999-302. PubMed ID: 3753512
[No Abstract] [Full Text] [Related]
6. Polymorphic sulphoxidation of carbocisteine.
Meese CO; Hofmann U; Eichelbaum M
Lancet; 1990 Sep; 336(8716):693-4. PubMed ID: 1975882
[No Abstract] [Full Text] [Related]
7. Genetically determined impaired drug sulphoxidation.
Waring RH; Mitchell SC; Idle JR; Smith RL
Lancet; 1981 Apr; 1(8223):778. PubMed ID: 6110975
[No Abstract] [Full Text] [Related]
8. Impaired sulfoxidation in patients with primary biliary cirrhosis.
Scharschmidt BF; Lake JR
Hepatology; 1989 Apr; 9(4):654-5. PubMed ID: 2925168
[No Abstract] [Full Text] [Related]
9. Does sulphoxidation state predict gold toxicity in rheumatoid arthritis?
Madhok R; Capell HA; Waring R
Br Med J (Clin Res Ed); 1987 Feb; 294(6570):483. PubMed ID: 3103737
[No Abstract] [Full Text] [Related]
10. Carbocisteine sulphoxidation phenotype.
Waring RH; Mitchell SC
Lancet; 1990 Jun; 335(8704):1527. PubMed ID: 1972452
[No Abstract] [Full Text] [Related]
11. Evaluation of proposed sulphoxidation pathways of carbocysteine in man by HPLC quantification.
Brockmöller J; Staffeldt B; Roots I
Eur J Clin Pharmacol; 1991; 40(4):387-92. PubMed ID: 2050173
[TBL] [Abstract][Full Text] [Related]
12. Genetic aspects of the polymodally distributed sulphoxidation of S-carboxymethyl-L-cysteine in man.
Mitchell SC; Waring RH; Haley CS; Idle JR; Smith RL
Br J Clin Pharmacol; 1984 Oct; 18(4):507-21. PubMed ID: 6487492
[TBL] [Abstract][Full Text] [Related]
13. Polymorphic sulphoxidation of S-carboxymethyl-L-cysteine in man.
Waring RH; Mitchell SC; Shah RR; Idle JR; Smith RL
Biochem Pharmacol; 1982 Oct; 31(19):3151-4. PubMed ID: 7150344
[No Abstract] [Full Text] [Related]
14. Genetic factors influencing the outcome of early arthritis--the role of sulphoxidation status.
Emery P; Bradley H; Arthur V; Tunn E; Waring R
Br J Rheumatol; 1992 Jul; 31(7):449-51. PubMed ID: 1628166
[TBL] [Abstract][Full Text] [Related]
15. The deficiency of sulfoxidation of S-carboxymethyl-L-cysteine.
Mitchell SC; Waring RH
Pharmacol Ther; 1989; 43(2):237-49. PubMed ID: 2675135
[No Abstract] [Full Text] [Related]
16. Epidemiology and genetics of primary biliary cirrhosis.
James OF; Myszor M
Prog Liver Dis; 1990; 9():523-36. PubMed ID: 2156312
[No Abstract] [Full Text] [Related]
17. A proposed mechanism for chlorpromazine jaundice--defective hepatic sulphoxidation combined with rapid hydroxylation.
Watson RG; Olomu A; Clements D; Waring RH; Mitchell S; Elias E
J Hepatol; 1988 Aug; 7(1):72-8. PubMed ID: 3183354
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of S-carboxymethyl-L-cysteine for otitis media with effusion.
Steventon GB; Mitchell SC
Ear Nose Throat J; 2006 May; 85(5):296-7. PubMed ID: 16771015
[No Abstract] [Full Text] [Related]
19. Variation in human metabolism of S-carboxymethylcysteine.
Waring RH
Eur J Drug Metab Pharmacokinet; 1980; 5(1):49-52. PubMed ID: 7389752
[TBL] [Abstract][Full Text] [Related]
20. An investigation of the metabolism of S-carboxymethyl-L-cysteine in man using a novel HPLC-ECD method.
Karim EF; Millership JS; Temple DJ; Woolfson AD
Eur J Drug Metab Pharmacokinet; 1988; 13(4):253-6. PubMed ID: 3243319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
